1756 related articles for article (PubMed ID: 31560247)
61. Markov's modeling for screening strategies for colorectal cancer.
Barouni M; Larizadeh MH; Sabermahani A; Ghaderi H
Asian Pac J Cancer Prev; 2012; 13(10):5125-9. PubMed ID: 23244122
[TBL] [Abstract][Full Text] [Related]
62. Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.
Ladabaum U; Ferrandez A; Lanas A
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2765-76. PubMed ID: 20810603
[TBL] [Abstract][Full Text] [Related]
63. Cost-Effectiveness of Current Colorectal Cancer Screening Tests.
Ladabaum U
Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):479-497. PubMed ID: 32439083
[TBL] [Abstract][Full Text] [Related]
64. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.
Song K; Fendrick AM; Ladabaum U
Gastroenterology; 2004 May; 126(5):1270-9. PubMed ID: 15131787
[TBL] [Abstract][Full Text] [Related]
65. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
Ladabaum U; Allen J; Wandell M; Ramsey S
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
[TBL] [Abstract][Full Text] [Related]
66. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.
Fisher DA; Karlitz JJ; Jeyakumar S; Smith N; Limburg P; Lieberman D; Fendrick AM
J Med Econ; 2021; 24(1):654-664. PubMed ID: 33902366
[TBL] [Abstract][Full Text] [Related]
67. Economic evaluation of colorectal cancer screening programs: Affordability for the health service.
Coretti S; Ruggeri M; Dibidino R; Gitto L; Marcellusi A; Mennini FS; Cicchetti A
J Med Screen; 2020 Dec; 27(4):186-193. PubMed ID: 31948342
[TBL] [Abstract][Full Text] [Related]
68. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing.
Berger BM; Parton MA; Levin B
Am J Manag Care; 2016 Feb; 22(2):e77-81. PubMed ID: 26881323
[TBL] [Abstract][Full Text] [Related]
69. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.
Knudsen AB; Hur C; Gazelle GS; Schrag D; McFarland EG; Kuntz KM
Ann Intern Med; 2012 Nov; 157(9):611-20. PubMed ID: 23128861
[TBL] [Abstract][Full Text] [Related]
70. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
[TBL] [Abstract][Full Text] [Related]
71. Cost-effectiveness analysis of different screening strategies for colorectal cancer in Guangzhou, southern China: a Markov simulation analysis based on natural community screening results.
Zhou Q; Li HL; Li Y; Gu YT; Liang YR; Liu HZ; Li K; Dong H; Chen YY; Lin GZ
BMJ Open; 2021 Sep; 11(9):e049581. PubMed ID: 34489283
[TBL] [Abstract][Full Text] [Related]
72. Colon Cancer Screening - Is It Time Yet?
Bhurgri H; Samiullah S
J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
[TBL] [Abstract][Full Text] [Related]
73. Cost Effectiveness of Mailed Outreach Programs for Colorectal Cancer Screening: Analysis of a Pragmatic, Randomized Trial.
Kapinos KA; Halm EA; Murphy CC; Santini NO; Loewen AC; Skinner CS; Singal AG
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2383-2392.e4. PubMed ID: 35144024
[TBL] [Abstract][Full Text] [Related]
74. Cost-Effectiveness of Earlier or More Intensive Colorectal Cancer Screening in Overweight and Obese Patients.
Yeoh A; Mannalithara A; Ladabaum U
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):507-519. PubMed ID: 35940514
[TBL] [Abstract][Full Text] [Related]
75. Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation.
Negrón ME; Kaplan GG; Barkema HW; Eksteen B; Clement F; Manns BJ; Coward S; Panaccione R; Ghosh S; Heitman SJ
Inflamm Bowel Dis; 2014 Nov; 20(11):2046-55. PubMed ID: 25230162
[TBL] [Abstract][Full Text] [Related]
76. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
77. Cost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic Review.
Ran T; Cheng CY; Misselwitz B; Brenner H; Ubels J; Schlander M
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1969-1981.e15. PubMed ID: 30659991
[TBL] [Abstract][Full Text] [Related]
78. As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia.
Parekh M; Fendrick AM; Ladabaum U
Aliment Pharmacol Ther; 2008 Apr; 27(8):697-712. PubMed ID: 18248653
[TBL] [Abstract][Full Text] [Related]
79. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.
Sharp L; Tilson L; Whyte S; O'Ceilleachair A; Walsh C; Usher C; Tappenden P; Chilcott J; Staines A; Barry M; Comber H
Br J Cancer; 2012 Feb; 106(5):805-16. PubMed ID: 22343624
[TBL] [Abstract][Full Text] [Related]
80. Cost effectiveness of CT colonography for UK NHS colorectal cancer screening of asymptomatic adults aged 60-69 years.
Lee D; Muston D; Sweet A; Cunningham C; Slater A; Lock K
Appl Health Econ Health Policy; 2010; 8(3):141-54. PubMed ID: 20369905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]